Inovio Pharmaceuticals (INO) Up on Positive H7N9 Flu Response in Preclinical Study
Tweet Send to a Friend
Inovio Pharmaceuticals, Inc. (NYSE: INO) is up 6% early after the company announced today that in a preclinical study of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
